mRNA vaccines follow unconventional immune path to destroy tumors
WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.
Environmental enrichment reduces fentanyl relapse in rats
A study by WashU Medicine researchers offers new insight into
how environmental factors protect against opioid addiction and support recovery.
Simple procedure relieves painful complications after deep vein thrombosis
A clinical trial co-led by WashU Medicine researchers has shown that a painful complication of blood clots can be treated by inserting a stent into the affected vein.
New research sheds light on the path of neurodegenerative diseases
Researchers from the WashU McKelvey School of Engineering are reshaping our understanding of disease origins and revealing how biomolecular condensates can tip cells from normal behavior to dysfunction.
When does the body clock begin to synchronize with local time?
New research from Washington University in St. Louis shows that a mother helps to set the biological clock for her babies while they are still in the womb.
New software safeguards research participants’ privacy
WashU Medicine researchers have developed a software, De-ID, that flags sensitive information in data collected through focus groups, surveys and interviews. It allows for easy removal of such details to enable safe sharing.
Probing a paradoxical drug response for irregular heartbeat
Research in Jon Silva’s lab at WashU McKelvey Engineering highlights the importance of genetic testing for precision medicine.
Eleven WashU faculty elected to AAAS
Eleven WashU faculty members are among the new fellows selected by the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.
American Society for Clinical Investigation honors early-career physician-scientists
WashU Medicine faculty members Mary M. Mullen, MD, an assistant professor in gynecologic oncology, and Siyan “Stewart” Cao, MD, PhD, an assistant professor in gastroenterology, have received the Young Physician-Scientist Award from the American Society for Clinical Investigation.
Older Stories